特集: 調査項目の変更・追加が可能なセミカスタムオーダー型の調査レポート(Lucintel社)はこちら

特集 : 国別の市場調査レポートをお探しの方はこちら

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心調律管理 (CRM) の世界市場:分析・規模・動向

Cardiac Rhythm Management Market Analysis, Size, Trends | Global | MedSuite

発行 iData Research Inc. 商品コード 918709
出版日 ページ情報 英文 754 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=108.13円で換算しております。

※ Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

心調律管理 (CRM) の世界市場:分析・規模・動向 Cardiac Rhythm Management Market Analysis, Size, Trends | Global | MedSuite
出版日: 2019年11月22日 ページ情報: 英文 754 Pages
概要

当レポートでは、世界の心調律管理 (CRM) 市場について調査分析し、疾患の概要、市場分析と予測、地域別予測、製品ポートフォリオなどについて、体系的な情報を提供しています。

エグゼクティブサマリー

世界の心調律管理 (CRM) ・電気生理学 (EP) ・心臓アブレーション市場の概要

競合分析

市場動向

市場の発展

処置件数

対象市場

対象地域

バージョン履歴

第1章 調査手法

第2章 疾患の概要

  • イントロダクション
  • 不整脈のタイプ
  • 心不全
  • 心停止
  • 患者人口統計

第3章 製品の評価

  • イントロダクション
  • 製品ポートフォリオ
    • ペースメーカー
    • 植込み型除細動器 (ICD)
    • 心臓再同期療法 (CRT) 装置
    • 心臓リード
    • 体外除細動器
    • ラボシステム
    • 診断用電気生理学 (EP) カテーテル
    • 心臓アブレーションカテーテル
  • FDAリコール
  • 治験

第4章 世界の心調律管理 (CRM) ・電気生理学 (EP) ・心臓アブレーション市場の概要

  • イントロダクション
  • 市場概要
  • 動向分析:セグメント別
  • 促進要因・抑制要因
  • 競合市場シェア分析
  • M&A
  • 企業プロファイル
  • SWOT分析

第5章 処置件数

  • イントロダクション
  • 処置

第6章 北米市場

  • イントロダクション
  • 市場概要
  • 市場分析・予測

第7章 ラテンアメリカ市場

  • イントロダクション
  • 市場概要
  • 市場分析・予測

第8章 西欧市場

  • イントロダクション
  • 市場概要
  • 市場分析・予測

第9章 中東欧市場

  • イントロダクション
  • 市場概要
  • 市場分析・予測

第10章 中東市場

  • イントロダクション
  • 市場概要
  • 市場分析・予測

第11章 アジア太平洋地域市場

  • イントロダクション
  • 市場概要
  • 市場分析・予測

第12章 アフリカ市場

  • イントロダクション
  • 市場概要
  • 市場分析・予測
図表

LIST OF CHARTS

  • Chart 1 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global, 2015 - 2025 3
  • Chart 1 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Overview, Global, 2018 & 2025 3
  • Chart 4 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global, 2015 - 2025 149
  • Chart 4 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Breakdown, Global, 2018 150
  • Chart 4 3: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Breakdown, Global, 2025 151
  • Chart 4 4: Growth Rates by Segment, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, Global, 2016 - 2025 154
  • Chart 4 5: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, Global, 2018 163
  • Chart 5 1: Procedures by Segment, Global, 2015 - 2025 189
  • Chart 5 2: Procedures by Segment, North America, 2015 - 2025 191
  • Chart 5 3: Procedures by Segment, Latin America, 2015 - 2025 194
  • Chart 5 4: Procedures by Segment, Western Europe, 2015 - 2025 201
  • Chart 5 5: Procedures by Segment, Central & Eastern Europe, 2015 - 2025 209
  • Chart 5 6: Procedures by Segment, Middle East, 2015 - 2025 218
  • Chart 5 7: Procedures by Segment, Asia-Pacific, 2015 - 2025 225
  • Chart 5 8: Procedures by Segment, Africa, 2015 - 2025 236
  • Chart 6 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, North America, 2015 - 2025 247
  • Chart 6 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Breakdown, North America, 2018 248
  • Chart 6 3: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Breakdown, North America, 2025 249
  • Chart 6 4: Pacemaker Market by Segment, North America, 2015 - 2025 253
  • Chart 6 5: ICD Market by Segment, North America, 2015 - 2025 266
  • Chart 6 6: CRT Market by Segment, North America, 2015 - 2025 278
  • Chart 6 7: Cardiac Lead Market by Segment, North America, 2015 - 2025 291
  • Chart 6 8: Lab Systems Market by Segment, North America, 2015 - 2025 298
  • Chart 6 9: Diagnostic EP Catheter Market, North America, 2015 - 2025 304
  • Chart 6 10: Cardiac Ablation Catheter Market, North America, 2015 - 2025 308
  • Chart 7 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Latin America, 2015 - 2025 313
  • Chart 7 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Breakdown, Latin America, 2018 314
  • Chart 7 3: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Breakdown, Latin America, 2025 315
  • Chart 7 4: Pacemaker Market by Segment, Latin America, 2015 - 2025 319
  • Chart 7 5: ICD Market by Segment, Latin America, 2015 - 2025 332
  • Chart 7 6: CRT Market by Segment, Latin America, 2015 - 2025 344
  • Chart 7 7: Cardiac Lead Market by Segment, Latin America, 2015 - 2025 357
  • Chart 7 8: Lab Systems Market by Segment, Latin America, 2015 - 2025 364
  • Chart 7 9: Diagnostic EP Catheter Market, Latin America, 2015 - 2025 370
  • Chart 7 10: Cardiac Ablation Catheter Market, Latin America, 2015 - 2025 374
  • Chart 8 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Western Europe, 2015 - 2025 379
  • Chart 8 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Breakdown, Western Europe, 2018 380
  • Chart 8 3: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Breakdown, Western Europe, 2025 381
  • Chart 8 4: Pacemaker Market by Segment, Western Europe, 2015 - 2025 386
  • Chart 8 5: ICD Market by Segment, Western Europe, 2015 - 2025 399
  • Chart 8 6: CRT Market by Segment, Western Europe, 2015 - 2025 411
  • Chart 8 7: Cardiac Lead Market by Segment, Western Europe, 2015 - 2025 424
  • Chart 8 8: Lab Systems Market by Segment, Western Europe, 2015 - 2025 431
  • Chart 8 9: Diagnostic EP Catheter Market, Western Europe, 2015 - 2025 437
  • Chart 8 10: Cardiac Ablation Catheter Market, Western Europe, 2015 - 2025 441
  • Chart 9 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Central & Eastern Europe, 2015 - 2025 446
  • Chart 9 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Breakdown, Central & Eastern Europe, 2018 447
  • Chart 9 3: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Breakdown, Central & Eastern Europe, 2025 448
  • Chart 9 4: Pacemaker Market by Segment, Central & Eastern Europe, 2015 - 2025 452
  • Chart 9 5: ICD Market by Segment, Central & Eastern Europe, 2015 - 2025 465
  • Chart 9 6: CRT Market by Segment, Central & Eastern Europe, 2015 - 2025 477
  • Chart 9 7: Cardiac Lead Market by Segment, Central & Eastern Europe, 2015 - 2025 490
  • Chart 9 8: Lab Systems Market by Segment, Central & Eastern Europe, 2015 - 2025 497
  • Chart 9 9: Diagnostic EP Catheter Market, Central & Eastern Europe, 2015 - 2025 503
  • Chart 9 10: Cardiac Ablation Catheter Market, Central & Eastern Europe, 2015 - 2025 507
  • Chart 10 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Middle East, 2015 - 2025 512
  • Chart 10 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Breakdown, Middle East, 2018 513
  • Chart 10 3: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Breakdown, Middle East, 2025 514
  • Chart 10 4: Pacemaker Market by Segment, Middle East, 2015 - 2025 518
  • Chart 10 5: ICD Market by Segment, Middle East, 2015 - 2025 531
  • Chart 10 6: CRT Market by Segment, Middle East, 2015 - 2025 543
  • Chart 10 7: Cardiac Lead Market by Segment, Middle East, 2015 - 2025 556
  • Chart 10 8: Lab Systems Market by Segment, Middle East, 2015 - 2025 563
  • Chart 10 9: Diagnostic EP Catheter Market, Middle East, 2015 - 2025 569
  • Chart 10 10: Cardiac Ablation Catheter Market, Middle East, 2015 - 2025 573
  • Chart 11 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Asia-Pacific, 2015 - 2025 578
  • Chart 11 2: Asia-Pacific Market Breakdown, Asia-Pacific, 2018 579
  • Chart 11 3: Asia-Pacific Market Breakdown, Asia-Pacific, 2025 580
  • Chart 11 4: Pacemaker Market by Segment, Asia-Pacific, 2015 - 2025 584
  • Chart 11 5: ICD Market by Segment, Asia-Pacific, 2015 - 2025 597
  • Chart 11 6: CRT Market by Segment, Asia-Pacific, 2015 - 2025 609
  • Chart 11 7: Cardiac Lead Market by Segment, Asia-Pacific, 2015 - 2025 622
  • Chart 11 8: Lab Systems Market by Segment, Asia-Pacific, 2015 - 2025 629
  • Chart 11 9: Diagnostic EP Catheter Market, Asia-Pacific, 2015 - 2025 635
  • Chart 11 10: Cardiac Ablation Catheter Market, Asia-Pacific, 2015 - 2025 639
  • Chart 12 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Africa, 2015 - 2025 644
  • Chart 12 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Breakdown, Africa, 2018 645
  • Chart 12 3: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Breakdown, Africa, 2025 646
  • Chart 12 4: Pacemaker Market by Segment, Africa, 2015 - 2025 650
  • Chart 12 5: ICD Market by Segment, Africa, 2015 - 2025 663
  • Chart 12 6: CRT Market by Segment, Africa, 2015 - 2025 675
  • Chart 12 7: Cardiac Lead Market by Segment, Africa, 2015 - 2025 688
  • Chart 12 8: Lab Systems Market by Segment, Africa, 2015 - 2025 695
  • Chart 12 9: Diagnostic EP Catheter Market, Africa, 2015 - 2025 701
  • Chart 12 10: Cardiac Ablation Catheter Market, Africa, 2015 - 2025 705

LIST OF FIGURES

  • Figure 1-1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Share Ranking by

Segment, Global, 2018

  • Figure 1-2: Companies Researched in this Report, Global, 2018
  • Figure 1-3: Factors Impacting the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation

Market by Segment, Global (1 of 2)

  • Figure 1-4: Factors Impacting the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation

Market by Segment, U.S. (2 of 2)

  • Figure 1-5: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation

Market, Global, 2015 - 2019 (1 of 3)

  • Figure 1-6: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation

Market, Global, 2015 - 2019 (2 of 3)

  • Figure 1-7: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation

Market, Global, 2015 - 2019 (3 of 3)

  • Figure 1-8: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures Covered,

Global

  • Figure 1-9: CRM & EP Markets Covered, Global
  • Figure 1-10: CRM & EP Regions Covered, Global (1 of 2)
  • Figure 1-11: CRM & EP Regions Covered, Global (2 of 2)
  • Figure 1-12: Version History
  • Figure 3-1: Pacemaker Market Products by Company
  • Figure 3-2: ICD Market Products by Company
  • Figure 3-3: CRT Device Market Products by Company
  • Figure 3-4: Cardiac Leads Market Products by Company
  • Figure 3-5: External Defibrillator Market Products by Company
  • Figure 3-6: Lab Systems Market Products by Company
  • Figure 3-7: Diagnostic EP Catheter Market Products by Company
  • Figure 3-8: Cardiac Ablation Catheter Products by Company (1 of 2)
  • Figure 3-9: Cardiac Ablation Catheter Products by Company (2 of 2) ................................................ 70 Figure 3-10: Class 2 Device Recall Assurity
  • Figure 3-11: Class 2 Device Recall Zenex
  • Figure 3-12: Class 2 Device Recall Accent family of pacemakers
  • Figure 3-13: Class 1 Device Recall Fortify, Fortify Assura
  • Figure 3-14: Class 1 Device Recall Fortify, Unify, Assura, including Quadra
  • Figure 3-15: Class 2 Device Recall Ellipse
  • Figure 3-16: Class 2 Device Recall Allure Quadra
  • Figure 3-17: Class 2 Device Recall Anthem, Allure
  • Figure 3-18: Class 2 Device Recall Nuance
  • Figure 3-19: Class 1 Device Recall Optisure HV lead
  • Figure 3-20: Class 3 Device Recall FIRMap 60mm Catheter
  • Figure 3-21: Class 2 Device Recall TactiSys Quartz Pack, PN004 400
  • Figure 3-22: Class 2 Device Recall SMARTABLATE RF Generator System
  • Figure 3-23: Class 2 Device Recall ESSENTIO Pacemaker
  • Figure 3-24: Class 2 Device Recall PROPONENT Pacemaker
  • Figure 3-25: Class 2 Device Recall ACCOLADE Pacemaker
  • Figure 3-26: Class 2 Device Recall PROPONENT SR Pacemaker
  • Figure 3-27: Class 2 Device Recall PROPONENT DR Pacemaker
  • Figure 3-28: Class 2 Device Recall PROPONENT EL DR Pacemaker
  • Figure 3-29: Class 2 Device Recall PROPONENT VDD SL Pacemaker
  • Figure 3-30: Class 2 Device Recall PROPONENT VDD SL Pacemaker
  • Figure 3-31: Class 2 Device Recall ACCOLADE MRI EL DR Pacemaker
  • Figure 3-32: Class 2 Device Recall ACCOLADE MRI DR Pacemaker
  • Figure 3-33: Class 2 Device Recall ACCOLADE MRI SR Pacemaker
  • Figure 3-34: Class 2 Device Recall ACCOLADE EL DR Pacemaker
  • Figure 3-35: Class 2 Device Recall ACCOLADE DR Pacemaker
  • Figure 3-36: Class 2 Device Recall ACCOLADE SR Pacemaker
  • Figure 3-37: Class 2 Device Recall ESSENTIO MRI EL DR Pacemaker
  • Figure 3-38: Class 2 Device Recall ESSENTIO MRI DR Pacemaker
  • Figure 3-39: Class 2 Device Recall ESSENTIO MRI SR Pacemaker
  • Figure 3-40: Class 2 Device Recall ESSENTIO DR Pacemaker
  • Figure 3-41: Class 2 Device Recall ESSENTIO SR Pacemaker ....................................................................... 81 Figure 3-42: Class 2 Device Recall ALTRUA 2 EL DR Pacemaker
  • Figure 3-43: Class 2 Device Recall ALTRUA 2 SR Pacemaker
  • Figure 3-44: Class 2 Device Recall ALTRUA 2 DR Pacemaker
  • Figure 3-45: Class 2 Device Recall Accolade MRI and Essentio MRI pacemakers
  • Figure 3-46: Class 2 Device Recall Implantable Cardioverter Defibrillator (NonCRT)
  • Figure 3-47: Class 2 Device Recall RESONATE EL ICD VR
  • Figure 3-48: Class 2 Device Recall RESONATE EL ICD DR
  • Figure 3-49: Class 2 Device Recall EMBLEM SICD, Model A209
  • Figure 3-50: Class 2 Device Recall SQRX 1010 Pulse Generator
  • Figure 3-51: Class 2 Device Recall EMBLEM MRI SICD Model 219
  • Figure 3-52: Class 2 Device Recall SQRX Model 1010 Subcutaneous Pulse Generator
  • Figure 3-53: Class 2 Device Recall VISIONIST X4 CRTP (Cardiac Resynchronization Therapy Pacemaker) . 84
  • Figure 3-54: Class 2 Device Recall VALITUDE X4 CRTP (Cardiac Resynchronization Therapy Pacemaker) . 85
  • Figure 3-55: Class 2 Device Recall VALITUDE X4 CRTP Pacemaker
  • Figure 3-56: Class 2 Device Recall VALITUDE CRTP Pacemaker
  • Figure 3-57: Class 2 Device Recall VISIONIST X4 CRTP Pacemaker
  • Figure 3-58: Class 2 Device Recall VISIONIST CRTP Pacemaker
  • Figure 3-59: Class 2 Device Recall VALITUDE X4 CRTP Pacemaker
  • Figure 3-60: Class 2 Device Recall RESONATE X4 CRTD
  • Figure 3-61: Class 2 Device Recall MOMENTUM X4 CRTD
  • Figure 3-62: Class 2 Device Recall VIGILANT X4 CRTD
  • Figure 3-63: Class 2 Device Recall Boston Scientific, INGEVITY MRI Leads, Sterile EO, RxOnly
  • Figure 3-64: Class 2 Device Recall Maestro 4000 Cardiac Ablation System
  • Figure 3-65: Class 2 Device Recall CLEARSIGN II Amplifier for LABSYSTEM PRO EP Recording System
  • Figure 3-66: Class 3 Device Recall Cardiac Ablation Percutaneous Catheters
  • Figure 3-67: Class 1 Device Recall Intella Tip MiFi Open Irrigated Ablation Catheter
  • Figure 3-68: Class 2 Device Recall 9131 Defibrillator Electrodes
  • Figure 3-69: Class 2 Device Recall Medtronic Model 53401 Single Chamber External Pulse Generator
  • Figure 3-70: Class 2 Device Recall Medtronic Model 5392 Dual Chamber Temporary External Pulse

Generator

  • Figure 3-71: Class 2 Device Recall EnTrust Dual Chamber Implantable Cardioverter Defibrillator with

Atrial and Ventricular Therapies ................................................................................................................ 91 Figure 3-72: Class 2 Device Recall EnTrust Single Chamber Implantable Cardioverter Defibrillator with

Atrial and Ventricular Therapies

  • Figure 3-73: Class 2 Device Recall Medtronic EnTrust Escudo
  • Figure 3-74: Class 1 Device Recall Evera MRI XT DR ICD, Evera MRI XT VR ICD, Evera MRI S DR ICD
  • Figure 3-75: Class 1 Device Recall Visia AF MRI VR SureScan ICD
  • Figure 3-76: Class 1 Device Recall Visia AF VR ICD
  • Figure 3-77: Class 1 Device Recall Evera S DR ICD, Evera S VR ICD, Evera XT DR ICD, Evera XT VR ICD
  • Figure 3-78: Class 2 Device Recall Evera ICD
  • Figure 3-79: Class 2 Device Recall Viva ICD
  • Figure 3-80: Class 2 Device Recall Percepta CRTP MRI SureScan
  • Figure 3-81: Class 2 Device Recall Percepta Quad CRTP MRI SureScan
  • Figure 3-82: Class 1 Device Recall Amplia MRI CRTD, Amplia MRI Quad CRTD
  • Figure 3-83: Class 1 Device Recall Viva Quad S CRTD, Viva Quad XT CRTD, Viva S CRTD, Viva XT CRTD
  • Figure 3-84: Class 1 Device Recall Compia MRI CRTD, Compia MRI Quad CRTD
  • Figure 3-85: Class 2 Device Recall Amplia MRI Quad CRT0 SureScanClaria MRI Quad CRTD

SureScanCompia MRI Quad CRTD SureScan

  • Figure 3-86: Class 2 Device Recall InSync III
  • Figure 3-87: Class 2 Device Recall Medtronic, Temporary Pacing Lead System
  • Figure 3-88: Class 2 Device Recall Achieve Electrical Cable
  • Figure 3-89: Class 2 Device Recall Medtronic CryoConsole
  • Figure 3-90: Class 2 Device Recall Platinium DR 1510
  • Figure 3-91: Class 2 Device Recall Platinium VR 1210
  • Figure 3-92: Class 2 Device Recall Platinium DR DF4 1540
  • Figure 3-93: Class 2 Device Recall Platinium VR DF4 1240
  • Figure 3-94: Class 2 Device Recall PARADYM
  • Figure 3-95: Class 2 Device Recall OVATIO
  • Figure 3-96: Class 2 Device Recall INTENSIA
  • Figure 3-97: Class 2 Device Recall Platinium Implantable Cardiac Defibrillator and Resynchronization

Therapy Defibrillator

  • Figure 3-98: Class 2 Device Recall Platinium CRTD 1741
  • Figure 3-99: Class 2 Device Recall Platinium CRT DF1 1711
  • Figure 3-100: Class 2 Device Recall PARADYM .......................................................................................... 101 Figure 3-101: Class 2 Device Recall OVATIO
  • Figure 3-102: Class 2 Device Recall INTENSIA
  • Figure 3-103: Class 2 Device Recall HeartStart MRx Monitor/Defibrillator
  • Figure 3-104: Class 2 Device Recall Philips HeartStart FRx AED
  • Figure 3-105: Class 2 Device Recall Philips HeartStart (HS1) (Onsite/Home) AED
  • Figure 3-106: Class 3 Device Recall XL Defibrillator
  • Figure 3-107: Class 2 Device Recall Philips QCPR Meter CPR feedback device
  • Figure 3-108: Class 2 Device Recall HeartStart MRx Monitor/Defibrillator
  • Figure 3-109: Class 2 Device Recall Philips HeartStart
  • Figure 3-110: Class 2 Device Recall BW Lasso 2515 ANV eco Variable Diagnostic EP Catheter
  • Figure 3-111: Class 2 Device Recall Reprocessed LASSO NAV eco Electrophysiology Catheter
  • Figure 3-112: Class 2 Device Recall Reprocessed Coronary Sinus Diagnostic EP Catheter
  • Figure 3-113: Class 2 Device Recall Stryker Sustainability Solutions Reprocessed BW Lasso 2515 NAV eco

Variable Diagnostic

  • Figure 3-114: Class 2 Device Recall Stryker Sustainability Solutions
  • Figure 3-115: Class 2 Device Recall Daig Livewire Steerable and Supreme Fixed Curve Diagnostic

Electrophysiology Catheters

  • Figure 3-116: Class 2 Class 2 Device Recall OneStep CPR Complete
  • Figure 3-117: Class 2 Device Recall LifeVest Wearable Defibrillator
  • Figure 3-118: SJM Brady MRI Post Approval Study
  • Figure 3-119: Evaluation of Atrial Fibrillation Occurrence in Sick Sinus and Complete Atrioventricular

Block Patients After Pacemaker Implantation (AF-pacemaker Study)

  • Figure 3-120: Longitudinal Coverage With Evidence Development Study on Micra Leadless Pacemakers

  • Figure 3-121: Heart Failure Indication and Sudden Cardiac Death Prevention Trial Japan
  • Figure 3-122: BIO|MASTER.Edora Family Study
  • Figure 3-123: China Micra Transcatheter Pacing Study
  • Figure 3-124: Optimizing Pacemaker Therapy Using Multi-Point Pacing (the OPT-MPP Study)
  • Figure 3-125: Cardioversion, Ablation or Pace and Ablate for Persistent Atrial Fibrillation in Over 65s - The

CAPAPAF-65 Study

  • Figure 3-126: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes II
  • Figure 3-127: Observation of ImageReady™ MR Conditional Pacing System in China ............................. 111 Figure 3-128: Micra Transcatheter Pacing System Continued Access Study Protocol
  • Figure 3-129: Comparison of CRT-D and CRT-DX Systems (CRT-NEXT)
  • Figure 3-130: Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients with the Use

of a VDD-ICD Lead (Dx-AF)

  • Figure 3-131: Multicenter Automatic Defibrillator Implantation Trial with Subcutaneous Implantable

Cardioverter Defibrillator (MADIT S-ICD)

  • Figure 3-132: Extravascular ICD Pilot Study
  • Figure 3-133: Acute Feasibility Investigation of a New S-ICD Electrode Arrangement for Reduction of

Defibrillation Energies

  • Figure 3-134: Subcutaneous ICD Therapy Combined with VT Ablation for the Secondary Prevention of

Sudden Cardiac Death

  • Figure 3-135: BIO|MASTER.Ilivia Family/Plexa
  • Figure 3-136: The REACT-ICD Trial (REACT-ICD)
  • Figure 3-137: Prospective Randomized Trial Comparing TRIPLE Site ventricular Stimulation Versus

Conventional Pacing in CRT candidates: TRIPLEAD Trial

  • Figure 3-138: Can Cognitive Function be Improved by Cardiac Resynchronization Therapy? (COGNI-CRT)

  • Figure 3-139: Re-evaluation of Optimal Re-synchronization Therapy in Patients with Chronic Heart Failure

An Investigator-driven, Prospective, Parallel-group, Randomized, Open, Blinded Outcome Assessment

(PROBE), Multi-center Trial Without Investigational Medical Products (Proof of Strategy Trial)

  • Figure 3-140: Continued Access Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization

Algorithm in the Paradym RF SonR CRT-D

  • Figure 3-141: AV Optimization Delivered with Direct His Bundle Pacing, in Patients with Heart Failure,

Long PR Without Left Bundle Branch Block: Randomized Multi-center Clinical Outcome Study.

  • Figure 3-142: Heart Failure with Preserved Ejection Fraction Treated by Cardiac Resynchronization

Therapy Versus Rate Responsive Pacing: A Mechanistic Study

  • Figure 3-143: Cardiac Resynchronization in the Elderly: Piloting Pacemaker vs. Defibrillator Therapy

(Randomized Trial)

  • Figure 3-144: Assessment of Pacing Stimulus Conduction and Latency Measurements in CRT-D Patients

(BIO|PULSE)

  • Figure 3-145: A Multicentre Randomized Control Trial Comparing Standard Cardiac Resynchronization

Pacing with Triventricular Pacing ............................................................................................................. 119 Figure 3-146: Responders and Quadripolar LV Lead in CRT

  • Figure 3-147: Does Targeted LV Lead Positioning Towards Latest Local Electric Activation at CRT

Implantation Reduce Incidence of the Combined Endpoint "Death or Non-planned Hospitalization for

Heart Failure (HF)" in Patients with HF and Prolonged QRS

  • Figure 3-148: Plexa ICD Lead Registry
  • Figure 3-149: AXONE -Acute: Safety and Electrical Performance Evaluation of INVICTA Leads Models

Equipped with DF4 Connector

  • Figure 3-150: Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4

Connector (NAVIGATOR)

  • Figure 3-151: Avoid Transvenous Leads in Appropriate Subjects
  • Figure 3-152: Left Ventricular Septal Pacing: Potential Application for Cardiac Resynchronization Therapy

  • Figure 3-153: Quartet Lead and Resynchronization Therapy Options - Assessing the Response Rate at 6

Months in CRT Patients Implanted with a Quartet Left Ventricular (LV) Quadripolar Lead and the

MultiPoint Pacing (MPP) Feature Activated

  • Figure 3-154: Attain Stability™ Quad Clinical Study
  • Figure 3-155: Imaging Study of Lead Implant for His Bundle Pacing ((IMAGE-HBP))
  • Figure 3-156: The Efficacy of Single Coil Defibrillation Leads for Internal Cardioversion of Persistent Atrial

Fibrillation

  • Figure 3-157: Reverse RAMP Pacing to Terminate Ventricular Tachycardia (REV-RAMP)
  • Figure 3-158: AXONE -Acute: Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac

Resynchronization Therapy

  • Figure 3-159: A Clinical Evaluation of the Durata or Optisure High Voltage Leads and Ellipse VR ICD

Undergoing Magnetic Resonance Imaging, an Investigational Device Exemption (IDE) Study

  • Figure 3-160: Acute Extravascular Defibrillation Study
  • Figure 3-161: Quality of Cardiopulmonary Resuscitation Guided by AED vs Telephone-assistance
  • Figure 3-162: Accuracy of Instructional Diagrams for Automated External Defibrillator (AED) Pad

Positioning

  • Figure 3-163: RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)
  • Figure 3-164: Esophageal 3D Mapping System for Cardiac Arrhythmias: Pilot Study to Establish Basis for

Improved Arrhythmia Diagnostics Using the esoECG-3D Catheter

  • Figure 3-165: Real-time Electrogram Analysis for Drivers of AtRial Fibrillation (RADAR) ......................... 128 Figure 3-166: EnSite™ HD Grid Catheter Mapping System for Advanced High Density Three-Dimensional

Mapping in Non-Paroxysmal Atrial Fibrillation and Atrial Tachycardia

  • Figure 3-167: Clinical Utility and Validation of the Rhythmia Mapping System for the Treatment of

Cardiac Arrhythmias

  • Figure 3-168: Surface ECG Signal Recording for the Implantable Subcutaneous String Defibrillator (ISSD)

Detection Algorithm Performance Assessment

  • Figure 3-169: Surface Electrocardiogram (ECG) Signal Recording for Implantable Subcutaneous String

Defibrillator (ISSD) Development

  • Figure 3-170: Advanced Cardiac Therapeutics DiamondTemp TempeRAture-Controlled and Contact

Sensing RF Ablation Clinical Trial for Atrial Fibrillation

  • Figure 3-171: Visualization of Human Cardiovascular Anatomy With Foresight Intracardiac

Echocardiography (ICE) System

  • Figure 3-172: INtra-procedural ultraSound Imaging for DEtermination of Atrial Wall Thickness and Acute

Tissue Changes During Isolation of the Pulmonary Veins

  • Figure 3-173: EnSite Precision™ Cardiac Mapping System and EnSite Precision™ Software v2.0

Observational Registry

  • Figure 3-174: Visualization of Human Cardiovascular Anatomy With Foresight Intracardiac

Echocardiography (ICE) System

  • Figure 3-175: Esophageal 3D Mapping System for Cardiac Arrhythmias: Pilot Study to Establish Basis for

Improved Arrhythmia Diagnostics Using the esoECG-3D Catheter

  • Figure 3-176: EnSite™ HD Grid Catheter Mapping System for Advanced High Density Three-Dimensional

Mapping in Non-Paroxysmal Atrial Fibrillation and Atrial Tachycardia

  • Figure 3-177: DURABLE-I Study: Dielectric Unravelling of Radiofrequency ABLation Effectiveness
  • Figure 3-178: FIRE AND ICE II Trial Pilot
  • Figure 3-179: Safety and Effectiveness Evaluation of the Multi-Electrode Radiofrequency Balloon

Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation (STELLAR)

  • Figure 3-180: Clinical Study for Safety and Acute Performance Evaluation of the THERMOCOOL

SMARTTOUCH® SF-5D System Used With Fast Ablation Mode in Treatment of Patients With Paroxysmal

Atrial Fibrillation

  • Figure 3-181: Microfidelity (MIFI) Ablation Technology Versus Standard Ablation Catheter for

Atrioventricular Nodal Ablation A Comparative Pilot Study of Time to Success

  • Figure 3-182: Cardiovascular Magnetic Resonance-Guided Radiofrequency-Ablation for Atrial Flutter . 137
目次
Product Code: iDATA_GLBCRMEP19_MS

The full report suite on the global market for cardiac rhythm management, electrophysiology and cardiac ablation includes pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices (CRTs), cardiac leads, electrophysiology (EP) lab systems, diagnostic electrophysiology (EP) catheters and cardiac ablation catheters.

This report on cardiac rhythm management (CRM) devices analyzes the market for medical devices used for diagnosing and treating cardiac arrhythmias. The medical device markets included in this report are pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices (CRTs), cardiac stimulation leads, electrophysiology (EP) lab systems, diagnostic electrophysiology (EP) catheters and cardiac ablation catheters.

TABLE OF CONTENTS

TABLE OF CONTENTS I

LIST OF FIGURES XXII

LIST OF CHARTS XLI

EXECUTIVE SUMMARY 1

GLOBAL CARDIAC RHYTHM MANAGEMENT, ELECTROPHYSIOLOGY & CARDIAC ABLATION MARKET OVERVIEW 1

COMPETITIVE ANALYSIS 4

MARKET TRENDS 7

MARKET DEVELOPMENTS 9

PROCEDURE NUMBERS 12

MARKETS INCLUDED 13

REGIONS INCLUDED 14

VERSION HISTORY 16

RESEARCH METHODOLOGY 17

  • Step 1: Project Initiation & Team Selection 17
  • Step 2: Prepare Data Systems and Perform Secondary Research 20
  • Step 3: Preparation for Interviews & Questionnaire Design 22
  • Step 4: Performing Primary Research 23
  • Step 5: Research Analysis: Establishing Baseline Estimates 25
  • Step 6: Market Forecast and Analysis 26
  • Step 7: Identify Strategic Opportunities 28
  • Step 8: Final Review and Market Release 29
  • Step 9: Customer Feedback and Market Monitoring 30

DISEASE OVERVIEW 31

  • 2.1 INTRODUCTION 31
  • 2.2 TYPES OF ARRHYTHMIAS 32
    • 2.2.11 Atrial Fibrillation 32
    • 2.2.12 Bradycardia 33
    • 2.2.13 Conduction Disorders 33
      • 2.2.13.1 Bundle Branch Block 33
      • 2.2.13.2 Heart Block 34
      • 2.2.13.3 Long QT Syndrome (LQTS) 35
    • 2.2.14 Premature Contractions: PACs and PVCs 35
    • 2.2.15 Tachycardia 36
    • 2.2.16 Ventricular Fibrillation 37
    • 2.2.17 Other Rhythm Disorders 37
      • 2.2.17.1 Adams-Stokes Disease 37
      • 2.2.17.2 Atrial Flutter 38
      • 2.2.17.3 Sick Sinus syndrome 38
      • 2.2.17.4 Sinus Arrhythmia 38
      • 2.2.17.5 Wolff-Parkinson-White Syndrome (WPW) 38
    • 2.2.18 Types of Arrhythmia in Children 38
  • 2.3 HEART FAILURE 39
  • 2.4 CARDIAC ARREST 40
  • 2.5 PATIENT DEMOGRAPHICS 41
    • 2.5.11 Atrial Fibrillation 41
    • 2.5.12 Bradycardia 41
    • 2.5.13 Conduction Disorders 42
    • 2.5.14 Premature Contractions - PACs and PVCs 43
    • 2.5.15 Tachycardia 44
    • 2.5.16 Ventricular Fibrillation 44
    • 2.5.17 Other Rhythm Disorders 45

PRODUCT ASSESSMENT 46

  • 3.1 INTRODUCTION 46
  • 3.2 PRODUCT PORTFOLIOS 46
    • 3.2.1 Pacemakers 46
    • 3.2.2 Implantable Cardioverter Defibrillators (ICDs) 49
    • 3.2.3 Cardiac Resynchronization Therapy (CRT) Devices 51
    • 3.2.4 Cardiac Leads 53
    • 3.2.5 External Defibrillators 55
    • 3.2.6 Lab Systems 57
      • 3.2.6.1 Introduction 57
      • 3.2.6.2 3D Mapping Systems 57
      • 3.2.6.3 EP Recording Systems 58
      • 3.2.6.4 Remote Steering Systems 59
      • 3.2.6.5 RF Ablation Generator 59
      • 3.2.6.6 ICE Systems 59
      • 3.2.6.7 Product Matrix for Lab Systems: Core Companies 61
    • 3.2.7 Diagnostic EP Catheters 62
      • 3.2.7.1 Introduction 62
      • 3.2.7.2 Diagnostic EP Catheters 62
      • 3.2.7.3 ICE Catheters 63
    • 3.2.8 Cardiac Ablation Catheters 66
      • 3.2.8.1 Introduction 66
      • 3.2.8.2 RF Ablation Catheters 67
      • 3.2.8.3 Alternative Energy Catheters 68
      • 3.2.8.4 High Intensity Focused Ultrasound 68
  • 3.3 FDA RECALLS 71
    • 3.3.1 Abbott 71
      • 3.3.1.1 Pacemakers 71
      • 3.3.1.2 Implantable Cardioverter Defibrillators (ICDs) 72
      • 3.3.1.3 Cardiac Resynchronization Therapy (CRT) Devices 73
      • 3.3.1.4 Cardiac Leads 74
      • 3.3.1.5 EP Lab Devices 74
      • 3.3.1.6 Cardiac Ablation Catheter 75
    • 3.3.2 Biosense Webster 76
      • 3.3.2.1 EP Lab Devices 76
    • 3.3.3 Boston Scientific 77
      • 3.3.3.1 Pacemakers 77
      • 3.3.3.2 Implantable Cardioverter Defibrillators (ICDs) 83
      • 3.3.3.3 Cardiac Resynchronization Therapy (CRT) Devices 84
      • 3.3.3.4 Cardiac Leads 87
      • 3.3.3.5 EP Lab Devices 87
      • 3.3.3.6 RF Ablation Catheter 88
    • 3.3.4 Cardiac Science 89
      • 3.3.4.1 Automated External Defibrillator (AED) 89
    • 3.3.5 Medtronic 90
      • 3.3.5.1 Pacemakers 90
      • 3.3.5.2 Implantable Cardioverter Defibrillators (ICDs) 91
      • 3.3.5.3 Cardiac Resynchronization Therapy (CRT) Devices 94
      • 3.3.5.4 Cardiac Leads 97
      • 3.3.5.5 EP Lab Devices 97
    • 3.3.6 MicroPort 98
      • 3.3.6.1 Implantable Cardioverter Defibrillators (ICDs) 98
      • 3.3.6.2 Cardiac Resynchronization Therapy (CRT) Devices 100
    • 3.3.7 Philips Healthcare 102
      • 3.3.7.1 Automated External Defibrillator (AED) 102
    • 3.3.8 Stryker Sustainability Solutions 104
      • 3.3.8.1 Diagnostic EP Catheters 104
    • 3.3.9 ZOLL 106
      • 3.3.9.1 Automated External Defibrillator (AED) 106
      • 3.3.9.2 Wearable Cardioverter Defibrillator (WCD) 106
  • 3.4 CLINICAL TRIALS 107
    • 3.4.1 Pacemakers 107
    • 3.4.2 Implantable Cardioverter Defibrillators (ICDs) 111
    • 3.4.3 Cardiac Resynchronization Therapy (CRT) Devices 114
    • 3.4.4 Cardiac Leads 119
    • 3.4.5 External Defibrillators 125
    • 3.4.6 Lab Systems 126
      • 3.4.6.1 3D Mapping Systems 126
      • 3.4.6.2 EP Recording Systems 128
      • 3.4.6.3 RF Ablation Generators 129
      • 3.4.6.4 ICE Systems 130
    • 3.4.7 Diagnostic EP Catheters 132
      • 3.4.7.1 Diagnostic Catheter 132
    • 3.4.8 Cardiac Ablation Catheter 134
      • 3.4.8.1 RF Ablation Catheters 134
      • 3.4.8.2 Cryoablation Catheters 137
      • 3.4.8.3 Laser Ablation Catheters 143

GLOBAL CARDIAC RHYTHM MANAGEMENT, ELECTROPHYSIOLOGY & CARDIAC ABLATION MARKET OVERVIEW 145

  • 4.1 INTRODUCTION 145
  • 4.2 MARKET OVERVIEW 147
  • 4.3 TREND ANALYSIS BY SEGMENT 152
  • 4.4 DRIVERS AND LIMITERS 155
    • 4.4.1 Market Drivers 155
    • 4.4.2 Market Limiters 157
  • 4.5 COMPETITIVE MARKET SHARE ANALYSIS 160
  • 4.6 MERGERS AND ACQUISITIONS 164
  • 4.7 COMPANY PROFILES 165
    • 4.7.1 Abbott 165
    • 4.7.2 Biosense Webster 166
    • 4.7.3 Biotronik 167
    • 4.7.4 Boston Scientific 168
    • 4.7.5 Cardiac Science 170
    • 4.7.6 GE Healthcare 171
    • 4.7.7 Medtronic 172
    • 4.7.8 MicroPort 173
    • 4.7.9 ZOLL 175
  • 4.8 SWOT ANALYSIS 176
    • 4.8.1 Abbott 176
    • 4.8.2 Biosense Webster 178
    • 4.8.3 Biotronik 179
    • 4.8.4 Boston Scientific 180
    • 4.8.5 Cardiac Science 181
    • 4.8.6 GE Healthcare 182
    • 4.8.7 Medtronic 183
    • 4.8.8 MicroPort 184
    • 4.8.9 ZOLL 186

PROCEDURE NUMBERS 187

  • 5.1 INTRODUCTION 187
  • 5.2 PROCEDURES 188
    • 5.2.1 Global Procedures 188
    • 5.2.2 North America Procedures 190
      • 5.2.2.1 Canada 192
      • 5.2.2.2 U.S. 192
    • 5.2.3 Latin America Procedures 193
      • 5.2.3.1 Argentina 195
      • 5.2.3.2 Brazil 195
      • 5.2.3.3 Chile 196
      • 5.2.3.4 Colombia 196
      • 5.2.3.5 Jamaica 197
      • 5.2.3.6 Mexico 197
      • 5.2.3.7 Peru 198
      • 5.2.3.8 Venezuela 198
      • 5.2.3.9 Rest of Latin America 199
    • 5.2.4 Western Europe Procedures 200
      • 5.2.4.1 Austria 202
      • 5.2.4.2 Benelux 202
      • 5.2.4.3 France 203
      • 5.2.4.4 Germany 203
      • 5.2.4.5 Italy 204
      • 5.2.4.6 Portugal 204
      • 5.2.4.7 Scandinavia 205
      • 5.2.4.8 Spain 205
      • 5.2.4.9 Switzerland 206
      • 5.2.4.10 United Kingdom 206
      • 5.2.4.11 Rest of Western Europe 207
    • 5.2.5 Central & Eastern Europe Procedures 208
      • 5.2.5.1 Baltic States 210
      • 5.2.5.2 Bulgaria 210
      • 5.2.5.3 Croatia 211
      • 5.2.5.4 Czech Republic 211
      • 5.2.5.5 Greece 212
      • 5.2.5.6 Hungary 212
      • 5.2.5.7 Kazakhstan 213
      • 5.2.5.8 Poland 213
      • 5.2.5.9 Romania 214
      • 5.2.5.10 Russia 214
      • 5.2.5.11 Turkey 215
      • 5.2.5.12 Ukraine 215
      • 5.2.5.13 Rest of Central & Eastern Europe 216
    • 5.2.6 Middle East Procedures 217
      • 5.2.6.1 Bahrain 219
      • 5.2.6.2 Iran 219
      • 5.2.6.3 Israel 220
      • 5.2.6.4 Kuwait 220
      • 5.2.6.5 Oman 221
      • 5.2.6.6 Qatar 221
      • 5.2.6.7 Saudi Arabia 222
      • 5.2.6.8 United Arab Emirates 222
      • 5.2.6.9 Rest of Middle East 223
    • 5.2.7 Asia-Pacific Procedures 224
      • 5.2.7.1 Australia 226
      • 5.2.7.2 Brunei 226
      • 5.2.7.3 Cambodia 227
      • 5.2.7.4 China 227
      • 5.2.7.5 Hong Kong 228
      • 5.2.7.6 India 228
      • 5.2.7.7 Indonesia 229
      • 5.2.7.8 Japan 229
      • 5.2.7.9 Malaysia 230
      • 5.2.7.10 Myanmar 230
      • 5.2.7.11 New Zealand 231
      • 5.2.7.12 Singapore 231
      • 5.2.7.13 South Korea 232
      • 5.2.7.14 Taiwan 232
      • 5.2.7.15 Thailand 233
      • 5.2.7.16 The Philippines 233
      • 5.2.7.17 Vietnam 234
      • 5.2.7.18 Rest of Asia Pacific 234
    • 5.2.8 Africa Procedures 235
      • 5.2.8.1 Algeria 237
      • 5.2.8.2 Egypt 237
      • 5.2.8.3 Ghana 238
      • 5.2.8.4 Kenya 238
      • 5.2.8.5 Libya 239
      • 5.2.8.6 Morocco 239
      • 5.2.8.7 Nigeria 240
      • 5.2.8.8 South Africa 240
      • 5.2.8.9 Sudan 241
      • 5.2.8.10 Uganda 241
      • 5.2.8.11 Rest of Africa 242

NORTH AMERICA MARKET 243

  • 6.1 INTRODUCTION 243
    • 6.1.1 Countries Included 244
  • 6.2 MARKET OVERVIEW 245
  • 6.3 MARKET ANALYSIS AND FORECAST 250
    • 6.3.1 Total Pacemaker Market 250
      • 6.3.1.1.1 Single and Dual-Chamber Devices 250
      • 6.3.1.1.2 MRI-Compatible Pacemaker 251
      • 6.3.1.1.3 Initial Placement and Replacement of Pacemakers 251
      • 6.3.1.2 Market Overview 252
      • 6.3.1.3 Total Single-Chamber Pacemaker Market 255
      • 6.3.1.3.1 New Placement Single-Chamber Pacemaker Market 257
      • 6.3.1.3.2 Replacement Single-Chamber Pacemaker Market 258
      • 6.3.1.4 Total Dual-Chamber Pacemaker Market 259
      • 6.3.1.4.1 New Placement Dual-Chamber Pacemaker Market 261
      • 6.3.1.4.2 Replacement Dual-Chamber Pacemaker Market 262
    • 6.3.2 Total Implantable Cardiac Defibrillator Market 263
      • 6.3.2.1.1 Cardiac Resynchronization Therapy-Defibrillators 264
      • 6.3.2.2 Market Overview 265
      • 6.3.2.3 Total Single-Chamber ICD Market 268
      • 6.3.2.3.1 New Placement Single-Chamber ICD Market 270
      • 6.3.2.3.2 Replacement Single-Chamber ICD Market 271
      • 6.3.2.4 Total Dual-Chamber ICD Market 272
      • 6.3.2.4.1 New Placement Dual-Chamber ICD Market 274
      • 6.3.2.4.2 Replacement Dual-Chamber ICD Market 275
    • 6.3.3 Total Cardiac Resynchronization Therapy Market 276
      • 6.3.3.1.1 Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps) 276
      • 6.3.3.1.2 Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds) 276
      • 6.3.3.2 Market Overview 277
      • 6.3.3.3 Total CRT-P Market 280
      • 6.3.3.3.1 New Placement CRT-P Market 282
      • 6.3.3.3.2 Replacement CRT-P Market 283
      • 6.3.3.4 Total CRT-D Market 284
      • 6.3.3.4.1 New Placement CRT-D Market 286
      • 6.3.3.4.2 Replacement CRT-D Market 287
    • 6.3.4 Total Cardiac Lead Market 288
      • 6.3.4.1.1 Replacement of Leads 289
      • 6.3.4.2 Market Overview 290
      • 6.3.4.3 Pacing Lead Market 292
      • 6.3.4.4 Defibrillation Lead Market 293
      • 6.3.4.5 LV Lead Market 294
    • 6.3.5 Total Lab Systems Market 295
      • 6.3.5.1.1 3D Mapping Systems 295
      • 6.3.5.1.2 EP Recording Systems 296
      • 6.3.5.1.3 Remote Steering Systems 296
      • 6.3.5.2 Market Overview 297
      • 6.3.5.3 3D Mapping System Market 299
      • 6.3.5.4 EP Recording System Market 300
    • 6.3.6 Diagnostic EP Catheter Market 301
      • 6.3.6.1.1 Diagnostic Electrophysiology Catheters 301
      • 6.3.6.1.2 Intracardiac Echocardiography 301
      • 6.3.6.2 Market Overview 302
    • 6.3.7 Cardiac Ablation Catheter Market 305
      • 6.3.7.1.1 Alternative Arrhythmia Treatments 305
      • 6.3.7.1.2 Atrial Fibrillation 306
      • 6.3.7.2 Market Overview 307

LATIN AMERICA MARKET 309

  • 7.1 INTRODUCTION 309
    • 7.1.1 Countries Included 310
  • 7.2 MARKET OVERVIEW 311
  • 7.3 MARKET ANALYSIS AND FORECAST 316
    • 7.3.1 Total Pacemaker Market 316
      • 7.3.1.1.1 Single and Dual-Chamber Devices 316
      • 7.3.1.1.2 MRI-Compatible Pacemaker 317
      • 7.3.1.1.3 Initial Placement and Replacement of Pacemakers 317
      • 7.3.1.2 Market Overview 318
      • 7.3.1.3 Total Single-Chamber Pacemaker Market 321
      • 7.3.1.3.1 New Placement Single-Chamber Pacemaker Market 323
      • 7.3.1.3.2 Replacement Single-Chamber Pacemaker Market 324
      • 7.3.1.4 Total Dual-Chamber Pacemaker Market 325
      • 7.3.1.4.1 New Placement Dual-Chamber Pacemaker Market 327
      • 7.3.1.4.2 Replacement Dual-Chamber Pacemaker Market 328
    • 7.3.2 Total Implantable Cardiac Defibrillator Market 329
      • 7.3.2.1.1 Cardiac Resynchronization Therapy-Defibrillators 330
      • 7.3.2.2 Market Overview 331
      • 7.3.2.3 Total Single-Chamber ICD Market 334
      • 7.3.2.3.1 New Placement Single-Chamber ICD Market 336
      • 7.3.2.3.2 Replacement Single-Chamber ICD Market 337
      • 7.3.2.4 Total Dual-Chamber ICD Market 338
      • 7.3.2.4.1 New Placement Dual-Chamber ICD Market 340
      • 7.3.2.4.2 Replacement Dual-Chamber ICD Market 341
    • 7.3.3 Total Cardiac Resynchronization Therapy Market 342
      • 7.3.3.1.1 Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps) 342
      • 7.3.3.1.2 Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds) 342
      • 7.3.3.2 Market Overview 343
      • 7.3.3.3 Total CRT-P Market 346
      • 7.3.3.3.1 New Placement CRT-P Market 348
      • 7.3.3.3.2 Replacement CRT-P Market 349
      • 7.3.3.4 Total CRT-D Market 350
      • 7.3.3.4.1 New Placement CRT-D Market 352
      • 7.3.3.4.2 Replacement CRT-D Market 353
    • 7.3.4 Total Cardiac Lead Market 354
      • 7.3.4.1.1 Replacement of Leads 355
      • 7.3.4.2 Market Overview 356
      • 7.3.4.3 Pacing Lead Market 358
      • 7.3.4.4 Defibrillation Lead Market 359
      • 7.3.4.5 LV Lead Market 360
    • 7.3.5 Total Lab Systems Market 361
      • 7.3.5.1.1 3D Mapping Systems 361
      • 7.3.5.1.2 EP Recording Systems 362
      • 7.3.5.1.3 Remote Steering Systems 362
      • 7.3.5.2 Market Overview 363
      • 7.3.5.3 3D Mapping System Market 365
      • 7.3.5.4 EP Recording System Market 366
    • 7.3.6 Diagnostic EP Catheter Market 367
      • 7.3.6.1.1 Diagnostic Electrophysiology Catheters 367
      • 7.3.6.1.2 Intracardiac Echocardiography 367
      • 7.3.6.2 Market Overview 368
    • 7.3.7 Cardiac Ablation Catheter Market 371
      • 7.3.7.1.1 Alternative Arrhythmia Treatments 371
      • 7.3.7.1.2 Atrial Fibrillation 372
      • 7.3.7.2 Market Overview 373

WESTERN EUROPE MARKET 375

  • 8.1 INTRODUCTION 375
    • 8.1.1 Countries Included 376
  • 8.2 MARKET OVERVIEW 377
  • 8.3 MARKET ANALYSIS AND FORECAST 382
    • 8.3.1 Total Pacemaker Market 382
      • 8.3.1.1.1 Single and Dual-Chamber Devices 382
      • 8.3.1.1.2 MRI-Compatible Pacemaker 383
      • 8.3.1.1.3 Leadless Pacemaker 383
      • 8.3.1.1.4 Initial Placement and Replacement of Pacemakers 383
      • 8.3.1.2 Market Overview 385
      • 8.3.1.3 Total Single-Chamber Pacemaker Market 388
      • 8.3.1.3.1 New Placement Single-Chamber Pacemaker Market 390
      • 8.3.1.3.2 Replacement Single-Chamber Pacemaker Market 391
      • 8.3.1.4 Total Dual-Chamber Pacemaker Market 392
      • 8.3.1.4.1 New Placement Dual-Chamber Pacemaker Market 394
      • 8.3.1.4.2 Replacement Dual-Chamber Pacemaker Market 395
    • 8.3.2 Total Implantable Cardiac Defibrillator Market 396
      • 8.3.2.1.1 Cardiac Resynchronization Therapy-Defibrillators 397
      • 8.3.2.2 Market Overview 398
      • 8.3.2.3 Total Single-Chamber ICD Market 401
      • 8.3.2.3.1 New Placement Single-Chamber ICD Market 403
      • 8.3.2.3.2 Replacement Single-Chamber ICD Market 404
      • 8.3.2.4 Total Dual-Chamber ICD Market 405
      • 8.3.2.4.1 New Placement Dual-Chamber ICD Market 407
      • 8.3.2.4.2 Replacement Dual-Chamber ICD Market 408
    • 8.3.3 Total Cardiac Resynchronization Therapy Market 409
      • 8.3.3.1.1 Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps) 409
      • 8.3.3.1.2 Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds) 409
      • 8.3.3.2 Market Overview 410
      • 8.3.3.3 Total CRT-P Market 413
      • 8.3.3.3.1 New Placement CRT-P Market 415
      • 8.3.3.3.2 Replacement CRT-P Market 416
      • 8.3.3.4 Total CRT-D Market 417
      • 8.3.3.4.1 New Placement CRT-D Market 419
      • 8.3.3.4.2 Replacement CRT-D Market 420
    • 8.3.4 Total Cardiac Lead Market 421
      • 8.3.4.1.1 Replacement of Leads 422
      • 8.3.4.2 Market Overview 423
      • 8.3.4.2.1 Pacing Lead Market 425
      • 8.3.4.2.2 Defibrillation Lead Market 426
      • 8.3.4.2.3 LV Lead Market 427
    • 8.3.5 Total Lab Systems Market 428
      • 8.3.5.1.1 3D Mapping Systems 428
      • 8.3.5.1.2 EP Recording Systems 429
      • 8.3.5.1.3 Remote Steering Systems 429
      • 8.3.5.2 Market Overview 430
      • 8.3.5.3 3D Mapping System Market 432
      • 8.3.5.4 EP Recording System Market 433
    • 8.3.6 Diagnostic EP Catheter Market 434
      • 8.3.6.1.1 Diagnostic Electrophysiology Catheters 434
      • 8.3.6.1.2 Intracardiac Echocardiography 434
      • 8.3.6.2 Market Overview 435
    • 8.3.7 Cardiac Ablation Catheter Market 438
      • 8.3.7.1.1 Alternative Arrhythmia Treatments 438
      • 8.3.7.1.2 Atrial Fibrillation 439
      • 8.3.7.2 Market Overview 440

CENTRAL & EASTERN EUROPE MARKET 442

  • 9.1 INTRODUCTION 442
    • 9.1.1 Countries Included 443
  • 9.2 MARKET OVERVIEW 444
  • 9.3 MARKET ANALYSIS AND FORECAST 449
    • 9.3.1 Total Pacemaker Market 449
      • 9.3.1.1.1 Single and Dual-Chamber Devices 449
      • 9.3.1.1.2 MRI-Compatible Pacemaker 450
      • 9.3.1.1.3 Initial Placement and Replacement of Pacemakers 450
      • 9.3.1.2 Market Overview 451
      • 9.3.1.3 Total Single-Chamber Pacemaker Market 454
      • 9.3.1.3.1 New Placement Single-Chamber Pacemaker Market 456
      • 9.3.1.3.2 Replacement Single-Chamber Pacemaker Market 457
      • 9.3.1.4 Total Dual-Chamber Pacemaker Market 458
      • 9.3.1.4.1 New Placement Dual-Chamber Pacemaker Market 460
      • 9.3.1.4.2 Replacement Dual-Chamber Pacemaker Market 461
    • 9.3.2 Total Implantable Cardiac Defibrillator Market 462
      • 9.3.2.1.1 Cardiac Resynchronization Therapy-Defibrillators 463
      • 9.3.2.2 Market Overview 464
      • 9.3.2.3 Total Single-Chamber ICD Market 467
      • 9.3.2.3.1 New Placement Single-Chamber ICD Market 469
      • 9.3.2.3.2 Replacement Single-Chamber ICD Market 470
      • 9.3.2.4 Total Dual-Chamber ICD Market 471
      • 9.3.2.4.1 New Placement Dual-Chamber ICD Market 473
      • 9.3.2.4.2 Replacement Dual-Chamber ICD Market 474
    • 9.3.3 Total Cardiac Resynchronization Therapy Market 475
      • 9.3.3.1.1 Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps) 475
      • 9.3.3.1.2 Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds) 475
      • 9.3.3.2 Market Overview 476
      • 9.3.3.3 Total CRT-P Market 479
      • 9.3.3.3.1 New Placement CRT-P Market 481
      • 9.3.3.3.2 Replacement CRT-P Market 482
      • 9.3.3.4 Total CRT-D Market 483
      • 9.3.3.4.1 New Placement CRT-D Market 485
      • 9.3.3.4.2 Replacement CRT-D Market 486
    • 9.3.4 Total Cardiac Lead Market 487
      • 9.3.4.1.1 Replacement of Leads 488
      • 9.3.4.2 Market Overview 489
      • 9.3.4.3 Pacing Lead Market 491
      • 9.3.4.4 Defibrillation Lead Market 492
      • 9.3.4.5 LV Lead Market 493
    • 9.3.5 Total Lab Systems Market 494
      • 9.3.5.1.1 3D Mapping Systems 494
      • 9.3.5.1.2 EP Recording Systems 495
      • 9.3.5.1.3 Remote Steering Systems 495
      • 9.3.5.2 Market Overview 496
      • 9.3.5.3 3D Mapping System Market 498
      • 9.3.5.4 EP Recording System Market 499
    • 9.3.6 Diagnostic EP Catheter Market 500
      • 9.3.6.1.1 Diagnostic Electrophysiology Catheters 500
      • 9.3.6.1.2 Intracardiac Echocardiography 500
      • 9.3.6.2 Market Overview 501
    • 9.3.7 Cardiac Ablation Catheter Market 504
      • 9.3.7.1.1 Alternative Arrhythmia Treatments 504
      • 9.3.7.1.2 Atrial Fibrillation 505
      • 9.3.7.2 Market Overview 506

MIDDLE EAST MARKET 508

  • 10.1 INTRODUCTION 508
    • 10.1.1 Countries Included 509
  • 10.2 MARKET OVERVIEW 510
  • 10.3 MARKET ANALYSIS AND FORECAST 515
    • 10.3.1 Total Pacemaker Market 515
      • 10.3.1.1.1 Single and Dual-Chamber Devices 515
      • 10.3.1.1.2 MRI-Compatible Pacemaker 516
      • 10.3.1.1.3 Initial Placement and Replacement of Pacemakers 516
      • 10.3.1.2 Market Overview 517
      • 10.3.1.3 Total Single-Chamber Pacemaker Market 520
      • 10.3.1.3.1 New Placement Single-Chamber Pacemaker Market 522
      • 10.3.1.3.2 Replacement Single-Chamber Pacemaker Market 523
      • 10.3.1.4 Total Dual-Chamber Pacemaker Market 524
      • 10.3.1.4.1 New Placement Dual-Chamber Pacemaker Market 526
      • 10.3.1.4.2 Replacement Dual-Chamber Pacemaker Market 527
    • 10.3.2 Total Implantable Cardiac Defibrillator Market 528
      • 10.3.2.1.1 Cardiac Resynchronization Therapy-Defibrillators 529
      • 10.3.2.2 Market Overview 530
      • 10.3.2.3 Total Single-Chamber ICD Market 533
      • 10.3.2.3.1 New Placement Single-Chamber ICD Market 535
      • 10.3.2.3.2 Replacement Single-Chamber ICD Market 536
      • 10.3.2.4 Total Dual-Chamber ICD Market 537
      • 10.3.2.4.1 New Placement Dual-Chamber ICD Market 539
      • 10.3.2.4.2 Replacement Dual-Chamber ICD Market 540
    • 10.3.3 Total Cardiac Resynchronization Therapy Market 541
      • 10.3.3.1.1 Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps) 541
      • 10.3.3.1.2 Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds) 541
      • 10.3.3.2 Market Overview 542
      • 10.3.3.3 Total CRT-P Market 545
      • 10.3.3.3.1 New Placement CRT-P Market 547
      • 10.3.3.3.2 Replacement CRT-P Market 548
      • 10.3.3.4 Total CRT-D Market 549
      • 10.3.3.4.1 New Placement CRT-D Market 551
      • 10.3.3.4.2 Replacement CRT-D Market 552
    • 10.3.4 Total Cardiac Lead Market 553
      • 10.3.4.1.1 Replacement of Leads 554
      • 10.3.4.2 Market Overview 555
      • 10.3.4.3 Pacing Lead Market 557
      • 10.3.4.4 Defibrillation Lead Market 558
      • 10.3.4.5 LV Lead Market 559
    • 10.3.5 Total Lab Systems Market 560
      • 10.3.5.1.1 3D Mapping Systems 560
      • 10.3.5.1.2 EP Recording Systems 561
      • 10.3.5.1.3 Remote Steering Systems 561
      • 10.3.5.2 Market Overview 562
      • 10.3.5.3 3D Mapping System Market 564
      • 10.3.5.4 EP Recording System Market 565
    • 10.3.6 Diagnostic EP Catheter Market 566
      • 10.3.6.1.1 Diagnostic Electrophysiology Catheters 566
      • 10.3.6.1.2 Intracardiac Echocardiography 566
      • 10.3.6.2 Market Overview 567
    • 10.3.7 Cardiac Ablation Catheter Market 570
      • 10.3.7.1.1 Alternative Arrhythmia Treatments 570
      • 10.3.7.1.2 Atrial Fibrillation 571
      • 10.3.7.2 Market Overview 572

ASIA-PACIFIC MARKET 574

  • 11.1 INTRODUCTION 574
    • 11.1.1 Countries Included 575
  • 11.2 MARKET OVERVIEW 576
  • 11.3 MARKET ANALYSIS AND FORECAST 581
    • 11.3.1 Total Pacemaker Market 581
      • 11.3.1.1.1 Single and Dual-Chamber Devices 581
      • 11.3.1.1.2 MRI-Compatible Pacemaker 582
      • 11.3.1.1.3 Initial Placement and Replacement of Pacemakers 582
      • 11.3.1.2 Market Overview 583
      • 11.3.1.3 Total Single-Chamber Pacemaker Market 586
      • 11.3.1.3.1 New Placement Single-Chamber Pacemaker Market 588
      • 11.3.1.3.2 Replacement Single-Chamber Pacemaker Market 589
      • 11.3.1.4 Total Dual-Chamber Pacemaker Market 590
      • 11.3.1.4.1 New Placement Dual-Chamber Pacemaker Market 592
      • 11.3.1.4.2 Replacement Dual-Chamber Pacemaker Market 593
    • 11.3.2 Total Implantable Cardiac Defibrillator Market 594
      • 11.3.2.1.1 Cardiac Resynchronization Therapy-Defibrillators 595
      • 11.3.2.2 Market Overview 596
      • 11.3.2.3 Total Single-Chamber ICD Market 599
      • 11.3.2.3.1 New Placement Single-Chamber ICD Market 601
      • 11.3.2.3.2 Replacement Single-Chamber ICD Market 602
      • 11.3.2.4 Total Dual-Chamber ICD Market 603
      • 11.3.2.4.1 New Placement Dual-Chamber ICD Market 605
      • 11.3.2.4.2 Replacement Dual-Chamber ICD Market 606
    • 11.3.3 Total Cardiac Resynchronization Therapy Market 607
      • 11.3.3.1.1 Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps) 607
      • 11.3.3.1.2 Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds) 607
      • 11.3.3.2 Market Overview 608
      • 11.3.3.3 Total CRT-P Market 611
      • 11.3.3.3.1 New Placement CRT-P Market 613
      • 11.3.3.3.2 Replacement CRT-P Market 614
      • 11.3.3.4 Total CRT-D Market 615
      • 11.3.3.4.1 New Placement CRT-D Market 617
      • 11.3.3.4.2 Replacement CRT-D Market 618
    • 11.3.4 Total Cardiac Lead Market 619
      • 11.3.4.1.1 Replacement of Leads 620
      • 11.3.4.2 Market Overview 621
      • 11.3.4.3 Pacing Lead Market 623
      • 11.3.4.4 Defibrillation Lead Market 624
      • 11.3.4.5 LV Lead Market 625
    • 11.3.5 Total Lab Systems Market 626
      • 11.3.5.1.1 3D Mapping Systems 626
      • 11.3.5.1.2 EP Recording Systems 627
      • 11.3.5.1.3 Remote Steering Systems 627
      • 11.3.5.2 Market Overview 628
      • 11.3.5.3 3D Mapping System Market 630
      • 11.3.5.4 EP Recording System Market 631
    • 11.3.6 Diagnostic EP Catheter Market 632
      • 11.3.6.1.1 Diagnostic Electrophysiology Catheters 632
      • 11.3.6.1.2 Intracardiac Echocardiography 632
      • 11.3.6.2 Market Overview 633
    • 11.3.7 Cardiac Ablation Catheter Market 636
      • 11.3.7.1.1 Alternative Arrhythmia Treatments 636
      • 11.3.7.1.2 Atrial Fibrillation 637
      • 11.3.7.2 Market Overview 638

AFRICA MARKET 640

  • 12.1 INTRODUCTION 640
    • 12.1.1 Countries Included 641
  • 12.2 MARKET OVERVIEW 642
  • 12.3 MARKET ANALYSIS AND FORECAST 647
    • 12.3.1 Total Pacemaker Market 647
      • 12.3.1.1.1 Single and Dual-Chamber Devices 647
      • 12.3.1.1.2 MRI-Compatible Pacemaker 648
      • 12.3.1.1.3 Initial Placement and Replacement of Pacemakers 648
      • 12.3.1.2 Market Overview 649
      • 12.3.1.3 Total Single-Chamber Pacemaker Market 652
      • 12.3.1.3.1 New Placement Single-Chamber Pacemaker Market 654
      • 12.3.1.3.2 Replacement Single-Chamber Pacemaker Market 655
      • 12.3.1.4 Total Dual-Chamber Pacemaker Market 656
      • 12.3.1.4.1 New Placement Dual-Chamber Pacemaker Market 658
      • 12.3.1.4.2 Replacement Dual-Chamber Pacemaker Market 659
    • 12.3.2 Total Implantable Cardiac Defibrillator Market 660
      • 12.3.2.1.1 Cardiac Resynchronization Therapy-Defibrillators 661
      • 12.3.2.2 Market Overview 662
      • 12.3.2.3 Total Single-Chamber ICD Market 665
      • 12.3.2.3.1 New Placement Single-Chamber ICD Market 667
      • 12.3.2.3.2 Replacement Single-Chamber ICD Market 668
      • 12.3.2.4 Total Dual-Chamber ICD Market 669
      • 12.3.2.4.1 New Placement Dual-Chamber ICD Market 671
      • 12.3.2.4.2 Replacement Dual-Chamber ICD Market 672
    • 12.3.3 Total Cardiac Resynchronization Therapy Market 673
      • 12.3.3.1.1 Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps) 673
      • 12.3.3.1.2 Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds) 673
      • 12.3.3.2 Market Overview 674
      • 12.3.3.3 Total CRT-P Market 677
      • 12.3.3.3.1 New Placement CRT-P Market 679
      • 12.3.3.3.2 Replacement CRT-P Market 680
      • 12.3.3.4 Total CRT-D Market 681
      • 12.3.3.4.1 New Placement CRT-D Market 683
      • 12.3.3.4.2 Replacement CRT-D Market 684
    • 12.3.4 Total Cardiac Lead Market 685
      • 12.3.4.1.1 Replacement of Leads 686
      • 12.3.4.2 Market Overview 687
      • 12.3.4.3 Pacing Lead Market 689
      • 12.3.4.4 Defibrillation Lead Market 690
      • 12.3.4.5 LV Lead Market 691
    • 12.3.5 Total Lab Systems Market 692
      • 12.3.5.1.1 3D Mapping Systems 692
      • 12.3.5.1.2 EP Recording Systems 693
      • 12.3.5.1.3 Remote Steering Systems 693
      • 12.3.5.2 Market Overview 694
      • 12.3.5.3 3D Mapping System Market 696
      • 12.3.5.4 EP Recording System Market 697
    • 12.3.6 Diagnostic EP Catheter Market 698
      • 12.3.6.1.1 Diagnostic Electrophysiology Catheters 698
      • 12.3.6.1.2 Intracardiac Echocardiography 698
      • 12.3.6.2 Market Overview 699
    • 12.3.7 Cardiac Ablation Catheter Market 702
      • 12.3.7.1.1 Alternative Arrhythmia Treatments 702
      • 12.3.7.1.2 Atrial Fibrillation 703
      • 12.3.7.2 Market Overview 704

ABBREVIATIONS 706